Everolimus is used to prevent organ transplant rejection and to treat certain types of cancers and other medical conditions such as some neuroendocrine tumors and tuberous sclerosis complexassociated disorders.

The purpose of everolimus is to suppress immune system activity and inhibit cell growth by blocking the mammalian target of rapamycin (mTOR) pathway.

Everolimus is an immunosuppressant and targeted therapy medication that belongs to the mTOR inhibitor class and is used under medical supervision for specific approved conditions.